Cancer charities have condemned a decision not to licence a drug being trialled in our region which extends the life of women suffering the advanced stages of breast cancer.
The National Institute for Clinical Excellence - or NICE - says the drug "Perjeeta" isn't cost effective.
Perjeeta is currently being tested on women through the Christie Hospital in Manchester - but it isn't routinely available on the NHS.
Cancer charities and women taking the drug want NICE to reconsider .
Ashley Derricott reports.
More top news
Snow causes road closures and event cancellations
Icy start to the new week. Turning milder and more unsettled. The big thaw sets in...
We asked for your best snowy shots from Sunday's whiteout across the North West. Here's just a few of them.